Tipranavir dosage and administration

Revision as of 16:13, 9 January 2014 by Ahmed Zaghw (talk | contribs)
Jump to navigation Jump to search
Tipranavir
Aptivus® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Dosage And Administration

APTIVUS must be co-administered with ritonavir to exert its therapeutic effect. Failure to correctly co-administer APTIVUS with ritonavir will result in plasma levels of tipranavir that will be insufficient to achieve the desired antiviral effect and will alter some drug interactions.

APTIVUS co-administered with ritonavir capsules or solution can be taken with or without meals APTIVUS co-administered with ritonavir tablets must only be taken with meals

APTIVUS may be administered as either capsules or oral solution to either pediatric or adult patients.

Due to the need for co-administration of APTIVUS with ritonavir, please refer to the ritonavir prescribing information.[1]

References

  1. "APTIVUS (TIPRANAVIR) CAPSULE, LIQUID FILLED APTIVUS (TIPRANAVIR) SOLUTION [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.]".

Adapted from the FDA Package Insert.